Atossa Therapeutics's market cap is currently $105.66M. The company's EPS TTM is $-0.214; its P/E ratio is ―; Atossa Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -23.00K	$ -8.00K	$ -23.00K	$ -46.60K	$ -52.79K
Operating Income	$ -31.38M	$ -27.69M	$ -20.52M	$ -14.61M	$ -17.27M
EBITDA	$ -31.35M	$ -27.68M	$ -20.50M	$ -14.56M	$ -17.21M
Net Income	$ -30.09M	$ -26.23M	$ -20.61M	$ -21.10M	$ -17.24M
Balance Sheet
Cash & Short-Term Investments	$ 88.46M	$ 110.89M	$ 136.38M	$ 39.55M	$ 12.58M
Total Assets	$ 96.25M	$ 123.53M	$ 141.26M	$ 42.84M	$ 14.49M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 18.05K	$ 50.48K
Net Debt	$ -88.46M	$ -110.89M	$ -136.38M	$ -39.54M	$ -12.53M
Total Liabilities	$ 5.24M	$ 5.57M	$ 3.13M	$ 15.67M	$ 1.33M
Stockholders' Equity	$ 91.02M	$ 117.96M	$ 138.14M	$ 27.17M	$ 13.16M
Cash Flow
Free Cash Flow	$ -20.95K	$ -20.79M	$ -16.48M	$ -11.58M	$ -9.14M
Operating Cash Flow	$ -20.94K	$ -20.76M	$ -16.47M	$ -11.57M	$ -9.13M
Investing Cash Flow	$ -14.00	$ -4.73M	$ -9.00K	$ -9.37K	$ -7.63K
Financing Cash Flow	$ -1.48K	$ 0.00	$ 113.30M	$ 38.55M	$ 11.34M

Currency in USD

Atossa Therapeutics Earnings and Revenue History

Income Statement >

Atossa Therapeutics Debt to Assets

Balance Sheet >

Atossa Therapeutics Cash Flow

Cash Flow >

Atossa Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing